Impact of sludge recirculation ratios on the performance of anaerobic membrane bioreactor for wastewater treatment
[Display omitted] •PVDF hollow fiber membrane was applied in AnMBR for synthetic wastewater treatment.•Membrane flux 6 L/m2 h and recirculation ratio 3 were optimum operating conditions.•Lowest permeate COD 17.7 mg/L while highest biogas production 0.44 L/gCODremoved.•Side stream submerged membrane...
Gespeichert in:
Veröffentlicht in: | Bioresource technology 2019-09, Vol.288, p.121473-121473, Article 121473 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•PVDF hollow fiber membrane was applied in AnMBR for synthetic wastewater treatment.•Membrane flux 6 L/m2 h and recirculation ratio 3 were optimum operating conditions.•Lowest permeate COD 17.7 mg/L while highest biogas production 0.44 L/gCODremoved.•Side stream submerged membrane configuration enabled better hydrodynamic control.
The performance of a lab scale anaerobic membrane bioreactor (AnMBR) was evaluated for wastewater treatment. The efficacy of the system was determined at different operating conditions in terms of fluxes and recirculation ratios (R); 10.28 L/m2 h (R = 1, Phase I), 8.8 L/m2 h (R = 2, Phase II and R = 3, Phase III) and 6 L/m2 h (R = 2, Phase IV and R = 3, Phase V), respectively. In comparison with all the operating conditions tested, optimum efficacy of the system was found at flux of 6 L/m2 h and R of 3 in terms of highest COD removal (96.7%), and maximum biogas yield (0.44 L/g CODremoved). The MLSS and MLVSS concentrations under optimum phase were 6.23 and 4.83 g/L, respectively at OLR of 0.46 kg COD/m3 day. The system also exhibited significant reduction of foulants i.e. extracellular polymeric substances (EPS) and soluble microbial products (SMP) resulting in longer membrane runs in optimized phase. |
---|---|
ISSN: | 0960-8524 1873-2976 |
DOI: | 10.1016/j.biortech.2019.121473 |